American Academy of Emergency Medicine


Take a Survey for the Global Initiative for MRSA Pneumonia (GLIMP study group)

The evaluation of risk factors for methicillin-resistant S. aureus (MRSA) in patients with pneumonia coming from the community is crucial to identify the appropriate empiric antibiotic therapy. There is a clear need to assess the association between several risk factors and MRSA in a large international cohort of adult patients admitted to the hospital with either community-acquired pneumonia (CAP) or health care-associated pneumonia (HCAP). Ideally, more than 10,000 patients will be needed.

GLobal Initiative for MRSA Pneumonia (GLIMP study group) has been recently started at global level with the aim of performing just on February 2nd, 2015 a focused cross sectional audit on adult patients hospitalised with CAP/HCAP. During this 24-hour audit, each participating site will identify all adult patients currently hospitalised due to CAP and HCAP and will collect their demographics, comorbidities, risk factors for MRSA, microbiological data and antibiotics. The web-based one-page case report form will have only de-identifiable data. No follow-up outcomes will be collected. This investigator initiated research will be self supported by the GLIMP study group and no pharmaceutical companies will be involved in this study. The GLIMP study group hope to motivate young and new investigators as well as international experts to participate in this interesting project by recognising authorship to each participating member. The synopsis of the protocol will be ready for those who are interest in the next few days. 

For those of you who are interested in participating in this exciting project, please click on the link below and complete the 30-second survey by November 20th, 2014.


Thank you
-The GLIMP Study Group